BIT's 12th Annual World Cancer Congress-2019(WCC-2019)

WCC-2019 will provide a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer in the world. With the participation of outstanding international experts,


BIT's 12th Annual World Cancer Congress-2019(WCC-2019)will be held on May 15-17, 2019 in Osaka, Japan.
Given the major worldwide importance in cancer research, cancer therapies, and new drug trials, we should not only help ensure we’re apprised of current developments in the field but also reflect on new progress and look toward future challenges.

Renowned Speakers of WCC-2019
Dr. Stefan Scherer, Senior Vice President of Clinical Development & Deputy Chief Medical Officer, CMO Cellectis, USA Dr. Vladimir Lazar, Chief Scientific and Operating Officer
WIN Consortium, France
Dr. Margaret I. Fitch, Professor, University of Toronto, Canada
Dr. Tanya W. Moseley, Professor & Medical Director, Julie and Ben Rogers Breast Imaging Center, The University of Texas M.D. Anderson Cancer Center, USA Dr. Luzhe Sun, Professor, The University of Texas Health Science Center, USA Dr. Vinod K Prasad, Professor & Director of PBMT Fellowship Program, Duke University Medical Center, USA
Dr. Mahmoud Khalifa, The Donald F. Gleason Professor & Director, Masonic Cancer Center, University of Minnesota, USA Dr. Emil Toma, Full Clinical Professor, University of Montreal, Canada Dr. Tapan K. Bera, Associate Scientist, Laboratory of Molecular Biology, CCR, NCI, NIH, USA
Dr. Claudia Wagner, Associate Director, Immatics Biotechnologies GmbH, Germany Dr. Alexander A. Oraevsky, Chief Executive Officer & Chief Technology Officer, TomoWave Laboratories, Inc., USA Dr. Andre Tremblay, Professor, University of Montreal & Ste-Justine Hospital, Canada
Dr. Mark Paris, Director of Translational Applications, Mitra Biotech Inc., USA Dr. Philip Andrew Doble, Professor, University of Technology Sydney, Australia Dr. Corinne Isnard Bagnis, Professor, Pitie Salpetriere Hospital, France
Dr. Fumiaki Uchiumi, Professor, Tokyo University of Science, Japan Dr. Maria Marjorette O. Pena, Associate Professor & Director, Mouse Experimentation Core - Center for Colon Cancer Research, University of South Carolina, USA Dr. Xinjian Chen, Associate Professor, University of Utah School of Medicine, USA
Dr. Adolfo Cavalié, Professor, Experimental and Clinical Pharmacology and Toxicology, Saarland University, Germany Dr. Takahiro Miyazaki, Executive Director, Research Biology, Nektar Therapeutics, USA Dr. Ayako Wakatsuki Pedersen, Head of Translational Research, IO Biotech ApS, Denmark
Dr. Donatella Boschi, Associate Professor, University of Torino, Italy Dr. Arkadiusz Orzechowski, Professor, Warsaw University of Life Sciences – SGGW, Poland Dr. Kiven E. Lukong, Associate Professor, University of Saskatchewan, Canada
Dr. Beiyun Chen, Associate Professor, Mayo Clinic, USA Dr. Robyn A. Lindley, Associate Professor, The Victorian Comprehensive Cancer Centre, University of Melbourne, Australia Dr. Annette Byrne, Associate Professor, Royal College of Surgeons in Ire, Ireland
Exhibition and Poster

As part of the 2019 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.


Exhibition Date:
Set-up date: May 15, 2019
Show dates: May 15-17, 2019 09:00-18:00
Place: Osaka,Japan

Hosting Organization

BIT Group Global Ltd.

Supporting Organization
Cooperation Organization

Japan-China Business Co., Ltd.


International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2008-2019 BIT Congress Inc.